Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth Thomas

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Journal for Immunotherapy of Cancer|April 1, 2022
Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancerKaty McCann, Adrian von Witzleben, Jaya Thomas, et al.
Journal for Immunotherapy of Cancer|July 24, 2020
M1<sup>hot</sup> tumor-associated macrophages boost tissue-resident memory T cells infiltration and survival in human lung cancerEva M Garrido-Martin, Toby W P Mellows, James Clarke, et al.
Cell Death & Disease|September 24, 2019
Protein kinase C inhibitors override ZEB1-induced chemoresistance in HCCRahul Sreekumar, Muhammad Emaduddin, Hajir Al-Saihati, et al.
Frontiers in Immunology|September 19, 2022
Transcriptional analysis highlights three distinct immune profiles of high-risk oral epithelial dysplasiaChai Phei Gan, Bernard Kok Bang Lee, Shin Hin Lau, et al.
European Journal of Cancer (Oxford, England : 1990)|November 13, 2017
COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-lossSimon J Crabb, Karen Martin, Julia Abab, et al.
BMC Medical Genetics|April 27, 2016
Pathogenic copy number variants and SCN1A mutations in patients with intellectual disability and childhood-onset epilepsyAndrew E Fry, Elliott Rees, Rose Thompson, et al.
Cell Reports. Medicine|October 4, 2022
A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivoJasper Fuk-Woo Chan, Yoo Jin Oh, Shuofeng Yuan, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Journal for Immunotherapy of Cancer|April 1, 2022
Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancerKaty McCann, Adrian von Witzleben, Jaya Thomas, et al.
Journal for Immunotherapy of Cancer|July 24, 2020
M1<sup>hot</sup> tumor-associated macrophages boost tissue-resident memory T cells infiltration and survival in human lung cancerEva M Garrido-Martin, Toby W P Mellows, James Clarke, et al.
Cell Death & Disease|September 24, 2019
Protein kinase C inhibitors override ZEB1-induced chemoresistance in HCCRahul Sreekumar, Muhammad Emaduddin, Hajir Al-Saihati, et al.
Frontiers in Immunology|September 19, 2022
Transcriptional analysis highlights three distinct immune profiles of high-risk oral epithelial dysplasiaChai Phei Gan, Bernard Kok Bang Lee, Shin Hin Lau, et al.
European Journal of Cancer (Oxford, England : 1990)|November 13, 2017
COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-lossSimon J Crabb, Karen Martin, Julia Abab, et al.
BMC Medical Genetics|April 27, 2016
Pathogenic copy number variants and SCN1A mutations in patients with intellectual disability and childhood-onset epilepsyAndrew E Fry, Elliott Rees, Rose Thompson, et al.
Cell Reports. Medicine|October 4, 2022
A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivoJasper Fuk-Woo Chan, Yoo Jin Oh, Shuofeng Yuan, et al.
Pageof 7